ROAD TO UNDERSTANDING POLYPHARMACY. Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP

Size: px
Start display at page:

Download "ROAD TO UNDERSTANDING POLYPHARMACY. Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP"

Transcription

1 ROAD TO UNDERSTANDING POLYPHARMACY Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP

2 Definition occurs when: 1. a medical regimen includes at least one unnecessary medication 2. Medications have not been optimized for desired therapeutic goal implies the prescribing of too many medication for an individual patient with the associated higher risk of adverse reactions and interactions

3 Scope of the Problem At one large AF Medical Center - greater than 3,200 patients had 15 active prescriptions In one study - 40% of pts received Rx from provider other than PCM A study of elderly patients showed - drug related problems was the major OR contributing reason for hospital admission in 31% of cases

4 Many Causes of the Problem Prescriber-related - pressed for time, prescribe for every symptom, market pressure System-related - lack of central PCM, lack of incentives to reduce Patient-related - belief every symptom requires new Rx, search for miraculous cure, direct to consumer market pressure

5 Factors Contributing to Polypharmacy Increasing age Multiple symptoms Multiple medical problems Copious prescribing Multiple providers Lack of a PCM to coordinate therapy Use of multiple pharmacies Hoarding medications Self treatment

6 Complications of Polypharmacy Increased side effects Adverse drug reactions Drug-drug interaction Noncompliance with the medication regimen Increased Cost Directly due to medication Indirectly due to hospitalization or other treatment of adverse effects

7 Case Studies

8 Case I 81 yo wf with HTN and angina (stable). Pt is limited in ability to ambulate. Wt 105 lbs. HTN has been well controlled and need for SL NTG has been less than once in 4 months. Meds: NTG 1/150 SL prn long acting nifedipine (Adalat CC) 30mg qd HCTZ 25 mg qd Recently pt presented to PCM with the complaint of heartburn for which the provider prescribed rantidine 300mg hs. Four days later patient was admitted to the hospital for severe chest pain (not relieve with NTG).

9 Case I (Cont.) Discussion Questions - 1. What labs would you like on admission? 2. Any test you would perform? 3. What steps would you take to prevent this from happening?

10 Case II 62 yo wf, HTN, NIDDM, hypothyroid (thyroid ablation - 20 years ago), current weight = 171 lbs, 5 3, BG in the 200 +/- range, BP 145/85, last T4 high nl 4 years ago. Meds: propranolol 80mg qd HCTZ 50mg qd levothyroxine 0.1mg qd Glypizide 20mg bid (recent increase - 2 months earlier - no decrease in BG) various OTC medications for seasonal allergies and cough/cold Questions - 1. what should you do to bring this patients BG under control? 2. what changes in therapy would you recommend? Why?

11 Case III 58 yo wf, with depression, primary osteoporosis, mild HTN, mild RA, and GERD admitted to the hospital with severe mental confusion/agitation. Medications - fluoxetine 20 mg qd Calcium 500 mg qd Vitamin D 150 mcg qd enalapril 10 mg qd piroxicam 20 mg qd cimetadine 600 mg bid

12 Case III (Cont.) Discussion Questions - 1. What labs would you want on admission? 2. Are there any other test you would request? Free Ca++ was 9.1mg/dl 3. Manic phase of bipolar disorder? (orig thought of intern)

13 Case IV 26 yo male patient admitted to the ER and subsequently to the ICU for esophageal bleed. Pt was healthy and had no record of medications used. Pt required transfusion with two units of whole blood on the first night and aggressive pressor agents and balloon taponade finally stopped the bleeding.

14 Case IV (Cont.) Discussion Pt was not HTN, was not intoxicated, was in good health. Prior to admission he had been out working on some land he had purchased and was clearing the lot for a house trailer. His only complaint to his wife was very sore muscles. Any questions?

15 Case V 10 yo wm with dx of ADD, mother presents with a request to the new physician for the same meds the child had been on at a previous station Dexidrine 10mg spansule in AM Dexidrine 5mg spansule at noon Nortriptyline 25mg hs

16 Case V (Cont.) Discussion Do we need split dosing of dexidrine? What is the purpose of the nortriptyline? Could this regimen be simplified?

17 Case VI S: 52 yo BF referred for uncontrolled DM II, htn, medication intolerance O: HgA1C 11.6 (9/00) BS range in upper 200 to 300 range AST/ALT 93/93 (11/00) Chol 215, HDL 64, LDL 133, TG 89 (10/00) + proteinuria BP 162/102 (4/00) and 137/89 at home after addition of Plendil wt 213 lbs Allergies codeine patient denies any hypoglycemic episodes

18 Case VI (cont) O: (continued) Current MEDS: Avandia 8mg qd Glucotrol 10mg bid Altace 10 mg bid ECASA 325 qd Plendil 10 mg qd Benadryl 50-mg hs Metamucil QAM numerous medication not tolerated including: Elavil, Reglan, Metformin, Hytrin, Catapres and Tiazac What do you want to know at this point? DISCUSSION

19 Case VI (cont) A/P: 1. Possible absorption issue with metamucil taken with other meds 2. HTN (with comobidity DMII) max ACE, plendil appears to have been effective, recommend add HCTZ 12.5 qd to maximize ACE effect. 3. DM II If LFTs permit continue Avandia for 6 wk trial suggest re-challenge with Metformin IF SrCr < 1.3 initial trial was too aggressive on starting dose. D/C glucotrol if starting metformin consider insulin if above not successful 4. Hyperlipidemia defer until other changes are stable goal is LDL < 100 due to comorbidities

20 Simplifying Regimens Eliminate pharmacologic duplication Avoid combinations that augment side effects tricyclic antidepressant and diphenhydramine for sleep Avoid combinations that duplicate therapy sucralfate plus H2 antagonist Use single medications to manage multiple diseases ACE inhibitor for HTN and CHF, B-blocker for HTN and angina Avoid drugs that can exacerbate the patient s other medical conditions B-blocker used for HTN in a patient with asthma

21 Simplifying Regimens (Cont.) Decrease dosing frequency Best medication for the patient with the least frequent dosing interval (NOTE: QD verses BID - no statistical difference in compliance) Consider sustained-release dosage forms (cost could be a factor here)

22 Simplifying Regimens (Cont.) Regular review of drug regimen Is the patient compliant? Are all agents still needed? Can the regimen be simplified? Brown Bag session Inquire about OTC medication use Inquire about herbal remedies

23 Other Considerations Include other members of the health-care team Pharmacy consultation on high yield areas - inhalation therapy, multiple medication patients, diabetic teaching, etc. Nursing - disease targeted patient education - diabetic care classes for all new diag. diabetics, discharge counseling with primary family members Physical Therapy - increase patients own expectations Health Promotion - have patient share responsibility for their situation

24 THANK YOU

25

If a bad thing is happening to a patient, a drug did it until proven otherwise

If a bad thing is happening to a patient, a drug did it until proven otherwise Dr Vicki s First Rule of Geriatrics Deprescribing in the Elderly Victoria Braund MD, FACP, CMD Director, Division of Geriatrics NorthShore University HealthSystem Medical Director, Brandel Health & Rehab

More information

A Process for Performing Medication Assessments

A Process for Performing Medication Assessments A Process for Performing Medication Assessments Derek Jorgenson, BSP, PharmD, FCSHP College of Pharmacy and Nutrition University of Saskatchewan Objectives 1. Learn an overview of a medication assessment

More information

Disorders of Thyroid Function

Disorders of Thyroid Function Disorders of Thyroid Function Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Thyroid Hormone Axis Hypothalamus TRH

More information

PILLS, PILLS, and MORE PILLS! Sound principles of geriatric pharmacology

PILLS, PILLS, and MORE PILLS! Sound principles of geriatric pharmacology PILLS, PILLS, and MORE PILLS! Sound principles of geriatric pharmacology Tatyana Gurvich, Pharm.D. USC School of Pharmacy/UCI Sr. Health Center Glendale Adventist FPRP You re Only Old Once! Repeat after

More information

A C A D E M I C D E TA I L I N G C H O O S I N G W I S E LY C O N F E R E N C E O C T 2 1, PA M M C L E A N - V E Y S E Y B S C P H A R M D R

A C A D E M I C D E TA I L I N G C H O O S I N G W I S E LY C O N F E R E N C E O C T 2 1, PA M M C L E A N - V E Y S E Y B S C P H A R M D R PPI DEPRESCRIBING Canadian Deprescribing Network (CaDeN) goals are to: Reduce harm by raising awareness and cutting risky prescriptions for seniors by 50% by 2020. Promote health by ensuring access to

More information

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment

More information

TEAMcare Treat-to-Target Tools

TEAMcare Treat-to-Target Tools TEAMcare Treat-to-Target Tools The TEAMcare Treatment Discussion Tool (treatment protocol) Nurse Case Manager (NCM)-MD Treat-to-Target Discussion Tool for Treatment Enhancement Activation and Motivation

More information

Diabetes Mellitus in Older Adults. Presenter Disclosure Information

Diabetes Mellitus in Older Adults. Presenter Disclosure Information Diabetes Mellitus in Older Adults Medha Munshi, M.D. Joslin Diabetes Center Beth Israel Deaconess Medical Center Harvard Medical School Presenter Disclosure Information Medha Munshi Research grant from

More information

How to Conduct an Effective Medication Therapy Management Session in the Community Pharmacy

How to Conduct an Effective Medication Therapy Management Session in the Community Pharmacy How to Conduct an Effective Medication Therapy Management Session in the Community Pharmacy Presented by: Dale Christensen, University of North Carolina Susmita Chavala, Humana Ed Staffa, Community MTM

More information

Case 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized?

Case 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized? Case 1 A primary care colleague inquires what to do with a patient (HFrEF in NSR) who has a digoxin level of 2.8ng/ml. Level was obtained at 10am, patient takes all medications at one time upon arising

More information

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of

More information

Demystifying the Complex Patient

Demystifying the Complex Patient Demystifying the Complex Patient Jay Reaume, BSc, BScPhm, RPh, CDE Suzanne Singh, BScPhm, ACPR, PharmD, RPh May 30, 2015 Disclosures Jay Reaume No conflicts of interest to disclose Suzanne Singh No conflicts

More information

Reason for referral: provide patient education on management of hypoglycemia and glucose monitor

Reason for referral: provide patient education on management of hypoglycemia and glucose monitor Meet Robin Sawyer (otherwise known as PT 1): Let s Create a Care Plan! Reason for referral: provide patient education on management of hypoglycemia and glucose monitor History of present illness: 40 45

More information

To Take or Not To Take?

To Take or Not To Take? To Take or Not To Take? Assessment Question How do the terms adherence & compliance differ? 1. The terms are synonymous 2.Adherence assumes collaboration between patient & provider while compliance suggests

More information

Treat-to-Target Tools

Treat-to-Target Tools TEAMcare Care Manager Primary Care Provider Treat to Target Discussion Tool for Treatment Enhancement Activation and Motivation (TEAM) Depression, Diabetes and Coronary Heart Disease (CHD) Intervention

More information

Advanced Pharmacology Diabetes Homework

Advanced Pharmacology Diabetes Homework Advanced Pharmacology Diabetes Homework Points: 25 Comments: Name: Tracy Hill WU ID #: 20015608 E-mail: tracy.hill@washburn.edu _TH I hereby certify that the work submitted is my own, and that I have not

More information

Polypharmacy & De-prescribing In Older Adults

Polypharmacy & De-prescribing In Older Adults Polypharmacy & De-prescribing In Older Adults Maryland Association of Osteopathic Physicians Annual Meeting September 15, 2018 Elizabeth Phung, DO Lead Clinical Associate Physician Beacham Center for Geriatric

More information

Polypharmacy and Elders. Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging

Polypharmacy and Elders. Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging Polypharmacy and Elders Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging Prescription Medication Use In Elders 1 13% of the US population is age 65+ Age 65 years 13% Age 65+ account for 34% of

More information

Case Studies in T2DM A Comprehensive Management Approach

Case Studies in T2DM A Comprehensive Management Approach Case Studies in T2DM A Comprehensive Management Approach John E. Anderson, MD The Frist Clinic Nashville, TN 43 yo Latina woman with 5 yrs T2DM. Originally diagnosed with PCOS and IGT by GYN at 32 yo.

More information

Case Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic

Case Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic Case Discussions: Treatment Strategies for High Risk Populations Peter H. Jones MD, FNLA Associate Professor Methodist DeBakey Heart and Vascular Center Baylor College of Medicine Most Common Reasons for

More information

Does Adding Examples to the American Society of Anesthesiologists Physical Status Classification Improve Consistency in Assignment to Patients?

Does Adding Examples to the American Society of Anesthesiologists Physical Status Classification Improve Consistency in Assignment to Patients? Does Adding Examples to the American Society of Anesthesiologists Physical Status Classification Improve Consistency in Assignment to Patients? Submitted Abstract to the 2015 ASA Annual Meeting 10 Hypothetical

More information

Application of the Diabetes Algorithm to a Patient

Application of the Diabetes Algorithm to a Patient Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent

More information

Type 2 Diabetes Performance Improvement Initiative: Chart Reviews. Lara Zisblatt Boston University School of Medicine Boston, MA

Type 2 Diabetes Performance Improvement Initiative: Chart Reviews. Lara Zisblatt Boston University School of Medicine Boston, MA Type 2 Diabetes Performance Improvement Initiative: Chart Reviews Lara Zisblatt Boston University School of Medicine Boston, MA Participants in the Program 487 people registered 217 people started the

More information

Participants in the Program

Participants in the Program Type 2 Diabetes Performance Improvement Initiative: Chart Reviews Lara Zisblatt Boston University School of Medicine Boston, MA Participants in the Program 487 people registered 217 people started the

More information

Special Situations 1

Special Situations 1 Special Situations 1 Outline Continuous Nutrition Tube feeds TPN Steroids Pumps Perioperative BG Control 2 Patient receiving continuous TF or TPN Continuous nutrition coverage options: Analog q4hr Regular

More information

Interprofessional Outpatient Clinic Polypharmacy Management. Objectives

Interprofessional Outpatient Clinic Polypharmacy Management. Objectives Interprofessional Outpatient Clinic Polypharmacy Management Brett Hoffecker, MD University of Kansas School of Medicine Wichita Family Medicine Residency Program at Via Christi April 10th, 2015 Objectives

More information

Navigating the Road to Efficient Medication Use

Navigating the Road to Efficient Medication Use Navigating the Road to Efficient Medication Use Molly R. Sinert, RPh, PharmD Clinical Pharmacist HospiScript Services LLC a Catamaran Rx Company October 28, 2013 Objectives Describe the components of the

More information

New Concepts in Acute Coronary Syndromes Beyond 2000 (XX) Interactive Case Presentations

New Concepts in Acute Coronary Syndromes Beyond 2000 (XX) Interactive Case Presentations New Concepts in Acute Coronary Syndromes Beyond 2000 (XX) Interactive Case Presentations Dr. Richard Bon Surrey Memorial Hospital, Surrey, BC Canadian Cardiovascular Congress 2014 October 26, 2014 Conflicts

More information

LEARNING OBJECTIVES 2/20/2017

LEARNING OBJECTIVES 2/20/2017 HYPERTENSION IN PREGNANCY: PREVENTING SEVERE MATERNAL MORBIDITY & MORTALITY THROUGH THE IMPLEMENTATION OF EVIDENCED BASED PROTOCOLS Laura Senn, RN, PhD, CNS Sutter Medical Center, Sacramento LEARNING OBJECTIVES

More information

A Practical Approach to the Use of Diabetes Medications

A Practical Approach to the Use of Diabetes Medications A Practical Approach to the Use of Diabetes Medications Juan Pablo Frias, M.D., FACE President, National Research Institute, Los Angles, CA Clinical Faculty, University of California, San Diego, CA OUTLINE

More information

2018 SNPhA/Kroger National Clinical Skills Competition Charlotte, NC Division I

2018 SNPhA/Kroger National Clinical Skills Competition Charlotte, NC Division I 2018 SNPhA/Kroger National Clinical Skills Competition Charlotte, NC Division I CC I m not sleeping well, and this medication makes my mouth feel dry all the time. HPI John Doe is a 44-year-old African-American

More information

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE Management of DM in Older Adults: It s not all about sugar! Peggy Odegard, Pharm.D., BCPS, CDE Who needs treatment for DM? 87 year old, frail male with moderately severe dementia living in NH with persistent

More information

Individualizing Treatment Plans for Older Adults With T2DM

Individualizing Treatment Plans for Older Adults With T2DM Individualizing Treatment Plans for Older Adults With T2DM Key Slides from the Interactive Newsletter Hypoglycemia y in Older Adults Particularly dangerous, especially for those on insulin or secretagogues

More information

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture.

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. 1 Phar6122: CV section Date: 3/10/05 Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. Directions: This handout includes three chronic heart failure cases of increasing difficulty. In

More information

Matching, Fill in the Blank, Multiple Choice (1 point each)

Matching, Fill in the Blank, Multiple Choice (1 point each) Name Quiz 3 grade /out of 50 Session 2 Quiz 3 July 2018 Matching, Fill in the Blank, Multiple Choice (1 point each) 1) The prescription reads as follows Lopressor 50mg sig: 2 tab po bid dispense #60 tabs.

More information

Polypharmacy: So Many Drugs, So Little Time. Shannon O. Smith, MD General Internal Medicine Conference

Polypharmacy: So Many Drugs, So Little Time. Shannon O. Smith, MD General Internal Medicine Conference Polypharmacy: So Many Drugs, So Little Time Shannon O. Smith, MD General Internal Medicine Conference Objectives 1. Recognize polypharmacy and what it means to your patients 2. Fix it. Patient Susie Q

More information

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures

More information

Diabetes and the Heart

Diabetes and the Heart Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with

More information

STOPP and START criteria October 2011

STOPP and START criteria October 2011 # START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which

More information

How to Teach About Drugs and Aging

How to Teach About Drugs and Aging How to Teach About Drugs and Aging Brandon Koretz MD Assistant Clinical Professor Division of Geriatrics Challenges Prescription pad:internist::scalpel: Surgeon Artificial split between theory and practice

More information

Background. 1 11/20/2011 Steven Chen, PharmD; Sun Han, PharmD, USC School of Pharmacy

Background. 1 11/20/2011 Steven Chen, PharmD; Sun Han, PharmD, USC School of Pharmacy University of Southern California School of Pharmacy Medication Therapy Intervention & Safety Documentation Program User Manual (v 6.0, last updated 11/20/11) Steven Chen, Pharm.D., Associate Professor

More information

Disclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?

Disclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space? Disclosures JUPITER: The final frontier in statin utilization or an idea from outer space? Kathy E. Komperda, PharmD, BCPS Midwestern University Chicago College of Pharmacy kkompe@midwestern.edu 4/25/09

More information

Meds and Falls: Keep in Step with your Meds

Meds and Falls: Keep in Step with your Meds Meds and Falls: Keep in Step with your Meds Donna Bartlett PharmD, CGP, RPh Associate Professor-Pharmacy Practice MCPHS University Clinical Pharmacist-MCPHS University- Pharmacy Outreach Program donna.bartlett@mcphs.edu

More information

VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8''

VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8'' IMC Didactic Case-Diabetes Mellitus Chief Complaint "I was recently diagnosed with diabetes and would like to have my blood sugar tested. I think that my blood sugar is running low because I have the shakes

More information

Chronic Disease Management when Resources are Limited

Chronic Disease Management when Resources are Limited Chronic Disease Management when Resources are Limited Paul R. Larson MD, MS, DIM&PH Director, Global Health Education UPMC St. Margaret Family Medicine Residency Pittsburgh, PA larsonpr@upmc.edu Disclosures

More information

Objectives. End-of-Life Exercise. Palliative Care Can Help Patients and Decrease 30-Day Hospital Readmissions.

Objectives. End-of-Life Exercise. Palliative Care Can Help Patients and Decrease 30-Day Hospital Readmissions. Palliative Care Can Help Patients and Decrease 30-Day Hospital Readmissions. Objectives Describe how palliative care meets the needs of the patient and family. Discuss how out-patient palliative care can

More information

Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45

Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45 Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45 1. Your diabetic patient is to be started on an insulin drip at 8 units/hour. The insulin is supplied: 100 units in

More information

Long-Term Management Of the ACS Patient: State-of-the-Art. Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA

Long-Term Management Of the ACS Patient: State-of-the-Art. Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA Long-Term Management Of the ACS Patient: State-of-the-Art Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA Disclosures I have no disclosures. Case Study 45 y/o male admitted to

More information

"No FUNDS Left Behind": Maximizing Inpatient Revenue Capture Through Better Understanding and Use of Documentation and Coding Guidelines

No FUNDS Left Behind: Maximizing Inpatient Revenue Capture Through Better Understanding and Use of Documentation and Coding Guidelines "No FUNDS Left Behind": Maximizing Inpatient Revenue Capture Through Better Understanding and Use of Documentation and Coding Guidelines Workshop A01: SGIM 31 st Annual National Meeting Thursday April

More information

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD Polypharmacy and the Older Adult Leslie Baker, PharmD, BCGP Umanga Sharma, MD Objectives Identify what polypharmacy is Identify factors leading to polypharmacy Discuss consequences of polypharmacy Identify

More information

Diabetes Mellitus Case Study

Diabetes Mellitus Case Study COLORADO STATE UNIVERSITY Diabetes Mellitus Case Study Medical Nutrition Therapy By: Emily Lancaster 9/28/2012 [Type the abstract of the document here. The abstract is typically a short summary of the

More information

Patient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE

Patient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE Patient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE Dx/Hx: uncontrolled DM and HTN Lifestyle: Patient usually sleeps

More information

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)

More information

Hypertension and Cholesterol in the Elderly

Hypertension and Cholesterol in the Elderly Hypertension and Cholesterol in the Elderly Angela Sanford, MD Assistant Professor of Geriatrics Saint Louis University School of Medicine I have no relevant financial disclosures Cushman WC. The burden

More information

APhA March 2016 Annual Meeting Obesity Cases

APhA March 2016 Annual Meeting Obesity Cases APhA March 2016 Annual Meeting Obesity Cases Case #1 Pam is a 47 yo obese Caucasian woman; grade school teacher with a history of HTN, HoTR, and depression who presents for her annual physical. CC: I m

More information

Pharmacy Partnership to Improve Patient Outcomes

Pharmacy Partnership to Improve Patient Outcomes Pharmacy Partnership to Improve Patient Outcomes Minnesota Rural Health Conference Session 2B Ryan M. Harden, MD MS Kendra Metz, Pharm D Sarah Nelson, MD June 25, 2018 Involved Partners Involved Partners

More information

Introduction: Case One. Commonly used agents 4/10/2015

Introduction: Case One. Commonly used agents 4/10/2015 Introduction: Rates of herbal medications Source NHANEs 2007 17.9% current users PMID: 22030445 Surgical population 57% of population were ever users, PMID: 16% current users 15051013 Non-pregnant rural

More information

Clinical Policy: Ranolazine (Ranexa) Reference Number: CP.PMN.34 Effective Date: Last Review Date: 02.19

Clinical Policy: Ranolazine (Ranexa) Reference Number: CP.PMN.34 Effective Date: Last Review Date: 02.19 Clinical Policy: (Ranexa) Reference Number: CP.PMN.34 Effective Date: 08.01.09 Last Review Date: 02.19 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

Consists of a provider specifically trained in Risk Adjustment documentation and coding

Consists of a provider specifically trained in Risk Adjustment documentation and coding QRA Coaching Consists of a provider specifically trained in Risk Adjustment documentation and coding Mining medical records for Risk Adjustment diagnoses Available for one on one coaching on risk adjustment,

More information

Have participants measure their blood pressure daily at a standard time for two weeks. Obtain BP values from participant (fax, call, , mail).

Have participants measure their blood pressure daily at a standard time for two weeks. Obtain BP values from participant (fax, call,  , mail). Blood Pressure Management and Control Protocol BP Management: A) BP goal: Achieve blood pressure values less than 130/80mmHg. B) Process: Have participants measure their blood pressure daily at a standard

More information

Multiple Choice Questions

Multiple Choice Questions Multiple Choice Questions 25yo M presents without psychiatric or medical history, with complaint of tremor to the ER. He denies drinking alcohol but his friend at bedside takes you to the side and reports

More information

Learning Objectives. Outline 4/3/2018. Treatment Strategies to Maximize the Value of Diabetes Medications

Learning Objectives. Outline 4/3/2018. Treatment Strategies to Maximize the Value of Diabetes Medications Treatment Strategies to Maximize the Value of Diabetes Medications Presenters: Jennifer Toy, PharmD, BCACP and Crystal Zhou, PharmD, APh AHSCP, BCACP Learning Objectives 1. Discuss which patients may benefit

More information

A 45 year old African American man presents to the IMC with a chief complaint of my

A 45 year old African American man presents to the IMC with a chief complaint of my AN EVIDENCE BASED APPROACH TO HYPERTENSION AND HYPERLIPIDENIA: A CASE STUDY A 45 year old African American man presents to the IMC with a chief complaint of my pressure is high. Apparently he recently

More information

Pharmacotherapeutic Challenge Diuretic Resistance

Pharmacotherapeutic Challenge Diuretic Resistance Pharmacotherapeutic Challenge Diuretic Resistance Barry E. Bleske, Pharm. D, FCCP Associate Professor University of Michigan, College of Pharmacy Learning Objectives Describe the causes for HF readmission.

More information

Difficult to Treat Hypertension

Difficult to Treat Hypertension Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic

More information

It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia

It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia Jacqueline LaManna, PhD, ANP BC, BC ADM, CDE Holly Divine, PharmD, BCACP, CGP, CDE, FAPhA Disclosures Dr. Jacqueline LaManna

More information

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS Philip J. Schneider, MS, FASHP The University of Arizona College of Pharmacy Learning Objectives: Describe the medication-use system and all interdependent

More information

HERBAL APPROACHES TO HYPERLIPIDEMIA. Patrick M. Fratellone, MD, RH (AHG), FIM, FACC New York, New York

HERBAL APPROACHES TO HYPERLIPIDEMIA. Patrick M. Fratellone, MD, RH (AHG), FIM, FACC New York, New York HERBAL APPROACHES TO HYPERLIPIDEMIA Patrick M. Fratellone, MD, RH (AHG), FIM, FACC New York, New York Patrick M. Fratellone, MD, RH (AHG) FIM, FACC November, 2013 CASE PRESENTATIONS CASE #1 46 YEAR OLD

More information

Preventing Falls in Older Adults A Matter of Safety

Preventing Falls in Older Adults A Matter of Safety Preventing Falls in Older Adults A Matter of Safety Roger Tam, BSc. Pharm. Wal-Mart Clinical Designated Pharmacist Falls Prevention Pharmacist Specialist NCCHC-Pre/Post Test Educator Q.U.I.T Educator Overview

More information

HA CONVENTION Effectiveness of Pharmacist-led Frail Elderly Medication Service in Acute Geriatric Ward

HA CONVENTION Effectiveness of Pharmacist-led Frail Elderly Medication Service in Acute Geriatric Ward Effectiveness of Pharmacist-led Frail Elderly Medication Service in Acute Geriatric Ward HA CONVENTION 2017 Candis Chang Pharmacist Department of Pharmacy Ruttonjee and Tang Shiu Kin Hospitals Background

More information

Women and Vascular Disease

Women and Vascular Disease Women and Vascular Disease KEVIN F. REBECK PA-C VASCULAR TRANSPLANT SURGERY 1 The Scope of the Problem One woman dies every minute from cardiovascular disease in the U.S.! The Scope of the Problem CVD

More information

CURRENT CONTROVERSIES IN DIABETES CARE

CURRENT CONTROVERSIES IN DIABETES CARE CURRENT CONTROVERSIES IN DIABETES CARE Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest Diabetes Mellitus: U.S. Impact

More information

Patient Three Lindy Vargas Consult Note ONE YEAR AGO

Patient Three Lindy Vargas Consult Note ONE YEAR AGO Patient Three Lindy Vargas Consult Note ONE YEAR AGO Missed nutrition appt. # SIGNED BY RYAN SEAPEST MPH, CL NUTR ONE YEAR AGO 11 MONTHS AGO Follow Up 19 yo female w PMHx sig for MOBY type DM2, Hyperlipidemia,

More information

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS Hypertension and the Challenge of Adherence Geneva Clark Briggs, Pharm.D., BCPS Outline Brief overview of HTN and pharmacologic therapies Role of pharmacists in collaboration with patients and physicians

More information

CHF for Clinician. AtHomeCare.com

CHF for Clinician. AtHomeCare.com CHF for Clinician AtHomeCare.com CONTACT INFORMATION FOR CLIENTS Client s Name: SOC Date: Case Manager s Name: Phone #: Physician s Name: Phone: Emergency Contact Person s Name: Phone Number: MISSION STATEMENT

More information

Objectives. Type 2 Diabetes: Treating an Epidemic. Angela R. Newsome, Pharm.D Mission Hospitals/MAHEC Asheville, NC April 20, 2006

Objectives. Type 2 Diabetes: Treating an Epidemic. Angela R. Newsome, Pharm.D Mission Hospitals/MAHEC Asheville, NC April 20, 2006 Type 2 Diabetes: Treating an Epidemic Angela R. Newsome, Pharm.D Mission Hospitals/MAHEC Asheville, NC April 20, 2006 Objectives Discuss the health and economic burden of diabetes Discuss necessary lifestyle

More information

It takes a Village: Medication Management Partnering with patients to optimize medication outcomes

It takes a Village: Medication Management Partnering with patients to optimize medication outcomes It takes a Village: Medication Management Partnering with patients to optimize medication outcomes Minnesota Department of Health Asthma Alliance October 2013 Asthma Optimally Managed Per Minnesota Community

More information

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative BLCS 1-Clinical Overview Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative Fraser Health Guide To Person-Centered Medication Decisions Factors to Consider When Systematically

More information

Challenging Patients: Elderly Patient With Multiple Co morbidities Essentials of Family Medicine 1

Challenging Patients: Elderly Patient With Multiple Co morbidities Essentials of Family Medicine 1 Prescribing in the Elderly Resident s Guide Case 1 Mr. P R is a 90 y/o male with HTN, Type 2 DM, hyperlipidemia, peripheral neuropathy, visual impairment, hearing impairment and disequilibrium. Although

More information

Managing Pharmacy Expenses in PACE: A Case Based Discussion. Valencia P. Covington, MD, MPH Jennifer Keller, PharmD, BCPS, CGP June 5, 2016

Managing Pharmacy Expenses in PACE: A Case Based Discussion. Valencia P. Covington, MD, MPH Jennifer Keller, PharmD, BCPS, CGP June 5, 2016 Managing Pharmacy Expenses in PACE: A Case Based Discussion Valencia P. Covington, MD, MPH Jennifer Keller, PharmD, BCPS, CGP June 5, 2016 Disclosure: Valencia Covington I have no relationships, financial

More information

Case #3 Clinician. Past Medical History: hypertension, hypercholesterolemia, arthritis, seasonal allergies, remote history of stroke

Case #3 Clinician. Past Medical History: hypertension, hypercholesterolemia, arthritis, seasonal allergies, remote history of stroke Case #3 Clinician Be the clinician taking a best possible medication history Use the space below to document your best possible medication history You are going to see patient Frank Ribello Reason for

More information

AtheroRegression Clinic (ARC) Protocols

AtheroRegression Clinic (ARC) Protocols AtheroRegression Clinic (ARC) Protocols Dmitri Vasin, M.D. Drew Garcia, PA C ARC Goals of Therapy Targets are intentionally simplified and reduced to a bare minimum to keep patients and providers on the

More information

Individualizing Care for Patients with Type 2 Diabetes

Individualizing Care for Patients with Type 2 Diabetes Individualizing Care for Patients with Type 2 Diabetes Disclosures Speaker: AstraZeneca, Novo Nordisk, BI/Lilly, Valeritas, Takeda Advisor: Tandem Diabetes, Sanofi Objectives Develop individualized approaches

More information

Ambulatory Care Conference

Ambulatory Care Conference Ambulatory Care Conference David Stultz, MD August 28, 2002 Case Presentation 50 year old white female presents to ED with substernal chest pain. Pain started while driving, is left substernal in location

More information

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis

More information

Medically Complex Older Adults: The Pharmacotherapeutic Challenge

Medically Complex Older Adults: The Pharmacotherapeutic Challenge Medically Complex Older Adults: The Pharmacotherapeutic Challenge Bradley R. Williams, PharmD, CGP Professor, Clinical Pharmacy & Clinical Gerontology University of Southern California Presentation Objectives

More information

Treating Hyperlipidemias in Adults. Lisa R. Tannock MD Division of Endocrinology and Molecular Medicine, University of Kentucky Lexington KY VAMC

Treating Hyperlipidemias in Adults. Lisa R. Tannock MD Division of Endocrinology and Molecular Medicine, University of Kentucky Lexington KY VAMC Treating Hyperlipidemias in Adults Lisa R. Tannock MD Division of Endocrinology and Molecular Medicine, University of Kentucky Lexington KY VAMC Disclosures Conflicts: None Talk will address off-label

More information

Hypertension Pharmacotherapy: A Practical Approach

Hypertension Pharmacotherapy: A Practical Approach Hypertension Pharmacotherapy: A Practical Approach Ronald Victor, MD Burns & Allen Chair in Cardiology Director, The Hypertension Center Associate Director, The Heart Institute Hypertension Center 1. 2.

More information

Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017

Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017 Insert Logo or Org Name Here Primary Care Medical Directive for Hypertension Management Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017 Title:

More information

Lipids What s new? Meera Jain, MD Providence Portland Medical Center

Lipids What s new? Meera Jain, MD Providence Portland Medical Center Lipids 2016- What s new? Meera Jain, MD Providence Portland Medical Center 1 Can I trust the ASCVD risk calculator? Do harms outweigh benefits in primary prevention? Is there anything besides a statin?

More information

Getting Hypertension Under Control

Getting Hypertension Under Control Getting Hypertension Under Control Learning Objectives EXPLAIN the factors involved in patient medication non-adherence. OUTLINE the results of studies focusing on medication adherence issues in patients

More information

quoted South Park in a talk

quoted South Park in a talk So Many Drugs: Using the Updated Beers' List to Address Polypharmacy MONA Annual Meeting April 22, 2016 Just so I can tell my Teenage Boy I quoted South Park in a talk 1 Objectives: To discuss the potential

More information

XOLAIR (omalizumab) Prior Authorization

XOLAIR (omalizumab) Prior Authorization MP9309 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below May only be prescribed by Allergy, Pulmonary, Immunology or Dermatology specialists

More information

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure Tools for Targeting High Risk Patients in Your Practice Joseph Vande Griend, PharmD, BCPS, CGP Assistant Professor, University of Colorado Departments of Clinical Pharmacy and Family Medicine Skaggs School

More information

ANGINA PECTORIS. angina pectoris is a symptom of myocardial ischemia in the absence of infarction

ANGINA PECTORIS. angina pectoris is a symptom of myocardial ischemia in the absence of infarction Pharmacology Ezra Levy, Pharm.D. ANGINA PECTORIS A. Definition angina pectoris is a symptom of myocardial ischemia in the absence of infarction angina usually implies severe chest pain or discomfort during

More information

Chest Pain Acute Coronary Syndrome Version 4 4/10/17 This order set is designed to be used with an admission set or for a patient already admitted

Chest Pain Acute Coronary Syndrome Version 4 4/10/17 This order set is designed to be used with an admission set or for a patient already admitted Patient Name: Diagnosis: Allergies with reaction type: Chest Pain Acute Coronary Syndrome Version 4 4/10/17 This order set is designed to be used with an admission set or for a patient already admitted

More information

beclometasone 100 MDI 2 puffs twice a day (recently changed to non CFC (Clenil Modulite))

beclometasone 100 MDI 2 puffs twice a day (recently changed to non CFC (Clenil Modulite)) Case 1 Mr Thomson, a 32 year old asthmatic who is well known to you comes into your pharmacy. He is known to have a best peak flow of 640 L/min. He tells you that over the last few weeks he has been wakening

More information

Smoke-free Hospitals. Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service

Smoke-free Hospitals. Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service Smoke-free Hospitals Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service Today s Subjects 5A s and Clinician Training and Use with the Hospitalized Patient NRT use in

More information

WHAT S THE SKINNY ON WEIGHT LOSS MEDICATION SAFETY? January 25, 2019 Pennsylvania Pharmacists Association

WHAT S THE SKINNY ON WEIGHT LOSS MEDICATION SAFETY? January 25, 2019 Pennsylvania Pharmacists Association WHAT S THE SKINNY ON WEIGHT LOSS MEDICATION SAFETY? January 25, 2019 Pennsylvania Pharmacists Association MEGAN N DUNLOP, PHARMD, CTTS CLINICAL PHARMACIST, UPMC COMMUNITY PROVIDER SERVICES LEARNING OBJECTIVES

More information

Managing Complex Diabetic Patients in the Primary Care Setting. Tyree Morrison, CRNP, CDE Laura Previte, RN, BSN

Managing Complex Diabetic Patients in the Primary Care Setting. Tyree Morrison, CRNP, CDE Laura Previte, RN, BSN Managing Complex Diabetic Patients in the Primary Care Setting Tyree Morrison, CRNP, CDE Laura Previte, RN, BSN OBJECTIVES Discuss epidemiology of diabetes Present overview of current treatment guidelines

More information